ondansetron has been researched along with Dermatitis, Atopic in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ondansetron decreased pruritus intensity in prurigo simplex (four patients), asteatotic eczema (two patients), parapsoriasis en plaques, and pruritus of unknown origin (one patient each)." | 7.72 | [Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron]. ( Degitz, K; Schuh, T; Zenker, S, 2003) |
| "Ondansetron decreased pruritus intensity in prurigo simplex (four patients), asteatotic eczema (two patients), parapsoriasis en plaques, and pruritus of unknown origin (one patient each)." | 3.72 | [Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron]. ( Degitz, K; Schuh, T; Zenker, S, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zenker, S | 1 |
| Schuh, T | 1 |
| Degitz, K | 1 |
1 other study available for ondansetron and Dermatitis, Atopic
| Article | Year |
|---|---|
[Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antipruritics; Dermatitis, Atopic; Eczema; Female; Fo | 2003 |